Phase 0 Biodistribution of Novel Imaging for Resectable Pancreatic Cancer
NCT01962909
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
TERMINATED
Status
3
Enrollment
OTHER
Sponsor class
Stopped
From preliminary imaging data, the study was stopped due to futility.
Conditions
Pancreatic Ductal Adenocarcinoma
Interventions
DRUG:
PTP-01
Sponsor
University of Virginia